Cytokinetics (CYTK) Q4 2023 Earnings

2NovConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-1.45
-1.22
-0.99
-0.76

Details

Expected EPS
-0.76
Actual EPS
-1.35
Surprise EPS
-0.59
Surprise Percent
+77.63%

Description

Cytokinetics (CYTK) has reported earnings of -1.35 per share for Q4 2023.

0 Comments

Share your thoughts